A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free

A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free

Conservative entrepreneur Vivek RamaswamyScott Olson/Getty Images <ul> <li>Roche acquired a bowel-disease treatment from Roivant for over $7 billion, the Wall Street Journal reported.</li> <li>Roiva… [+2133 chars]

Read More